You are here

  • Home
  • Archive
  • Volume 5, Issue 12
  • COGNITIVE-HD study: protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis

Article Text

Article menu

Download PDFPDF

XML
Epidemiology
Protocol
COGNITIVE-HD study: protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis
  1. Suetonia C Palmer1,
  2. Marinella Ruospo2,3,
  3. Maria Rosaria Barulli4,
  4. Annalisa Iurillo4,
  5. Valeria Saglimbene2,
  6. Patrizia Natale2,
  7. Letizia Gargano2,
  8. Angelo M Murgo2,
  9. Clement Loy5,
  10. Anita van Zwieten6,
  11. Germaine Wong6,
  12. Rosanna Tortelli4,
  13. Jonathan C Craig6,
  14. David W Johnson7,
  15. Marcello Tonelli8,
  16. Jörgen Hegbrant2,
  17. Charlotta Wollheim2,
  18. Giancarlo Logroscino4,9,
  19. G F M Strippoli2,6,10,11
  20. on behalf of the COGNITIVE-HD Study investigators
    1. 1Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand
    2. 2Diaverum Medical Scientific Office, Lund, Sweden
    3. 3Division of Nephrology and Transplantation, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
    4. 4Neurodegenerative Diseases Unit, Department of Clinical Research in Neurology, University of Bari “A. Moro”, Tricase, Lecce, Italy
    5. 5Huntington Disease Service, Westmead Hospital, Westmead, NSW, Australia
    6. 6Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia
    7. 7Department of Nephrology, Princess Alexandra Hospital, Woolloongabba, Australia
    8. 8Cumming School of Medicine, Health Services, University of Calgary, Calgary, Alberta, Canada
    9. 9Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari “A. Moro”, Bari, Italy
    10. 10Department of Emergency and Organ Transplantation, University of Bari, Piazza Giulio Cesare, Bari, Italy
    11. 11Diaverum Academy, Bari, Italy
    1. Correspondence to Professor GFM Strippoli; gfmstrippoli{at}gmail.com

    Abstract

    Introduction The prevalence of cognitive impairment may be increased in adults with end-stage kidney disease compared with the general population. However, the specific patterns of cognitive impairment and association of cognitive dysfunction with activities of daily living and clinical outcomes (including withdrawal from treatment) among haemodialysis patients remain incompletely understood. The COGNITIVE impairment in adults with end-stage kidney disease treated with HemoDialysis (COGNITIVE-HD) study aims to characterise the age-adjusted and education-adjusted patterns of cognitive impairment (using comprehensive testing for executive function, perceptual-motor function, language, learning and memory, and complex attention) in patients on haemodialysis and association with clinical outcomes.

    Methods and analysis A prospective, longitudinal, cohort study of 750 adults with end-stage kidney disease treated with long-term haemodialysis has been recruited within haemodialysis centres in Italy (July 2013 to April 2014). Testing for neurocognitive function was carried out by a trained psychologist at baseline to assess cognitive functioning. The primary study factor is cognitive impairment and secondary study factors will be specific domains of cognitive function. The primary outcome will be total mortality. Secondary outcomes will be cause-specific mortality, major cardiovascular events, fatal and non-fatal myocardial infarction and stroke, institutionalisation, and withdrawal from treatment at 12 months.

    Ethics and dissemination This protocol was approved before study conduct by the following responsible ethics committees: Catania (approval reference 186/BE; 26/09/2013), Agrigento (protocol numbers 61–62; 28/6/2013), USL Roma C (CE 39217; 24/6/2013), USL Roma F (protocol number 0041708; 23/7/2013), USL Latina (protocol number 20090/A001/2011; 12/7/2013), Trapani (protocol number 3413; 16/7/2013) and Brindisi (protocol number 40259; 6/6/2013). All participants have provided written and informed consent and can withdraw from the study at any time. The findings of the study will be disseminated through peer-reviewed journals and national and international conference presentations and to the participants through communication within the dialysis network in which this study is conducted.

    This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

    https://doi.org/10.1136/bmjopen-2015-009328

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      View Full Text